Medical and Economic Outcomes of Point-of-Care Testing
-
Christopher P. Price
Abstract
Point-of-care testing is concerned with the immediacy of response, primarily because of the need to act in a life-threatening crisis or to provide counsel in the ongoing management of a chronic disease. There are both clinical, operational and economic benefits that can accrue from this testing modality which may be observed from several perspectives – the patient, the clinician, the healthcare provider, the healthcare purchaser and society. Thus point-of-care testing can improve the management of chronic diseases such as diabetes, compromised coagulation status and epilepsy – both in terms of optimisation of, and compliance with, therapy. There are also life-threatening crises that can be averted by rapid provision of test results. Each of these scenarios can lead to more efficient use of healthcare resources.
Copyright © 2002 by Walter de Gruyter GmbH & Co. KG
Artikel in diesem Heft
- New Developments in Clinical Chemistry and Laboratory Medicine as Documented by EUROMEDLAB 2001 the 14th IFCC-FESCC European Congress of Clinical Chemistry and Laboratory Medicine, Prague, May 2631, 2001
- Haptoglobin Polymorphism and Body Iron Stores
- Immunohistochemistry in the Evaluation of Spermatogenesis and Sertoli Cell's Maturation Status
- Study of Therapy Resistance in Cancer Cells with Functional Proteome Analysis
- Proposition of an Aging Indicator from General Health Examination in France
- Comparison of Plasma Cardiac Troponins T and I in Chronically Hemodialyzed Patients in Relation to Cardiac Status and Age
- Medical and Economic Outcomes of Point-of-Care Testing
- Are Laboratory Investigations Recommended in Current Medical Practice Guidelines Supported by Available Evidence?
- New Aspects on Angiotensin-Converting Enzyme: from Gene to Disease
- Oxypurines, Protein, Glucose and the Functional State of Blood Vasculature Are Markers of Renal Calcium Stone-forming Processes? Observations in Men with Idiopathic Recurrent Calcium Urolithiasis
- Long-Chain Polyunsaturated Fatty Acids in Rat Maternal Milk, Offspring Brain and Peripheral Tissues in Essential Fatty Acid Deficiency
- Simultaneous Quantification of Sirolimus, Everolimus, Tacrolimus and Cyclosporine by Liquid Chromatography-Mass Spectrometry (LC-MS)
- Pancreatic Phospholipase A2 Activity in Acute Pancreatitis: a Prognostic Marker for Early Identification of Patients at Risk
- Serum Cytokeratin Fragment 21.1 (CYFRA 21.1) as Tumour Marker for Breast Cancer: Comparison with Carbohydrate Antigen 15.3 (CA 15.3) and Carcinoembryonic Antigen (CEA)
- Serum Cholesterol Levels in Neutropenic Patients with Fever
- Evaluation of Two Mg2+-Selective Electrodes by Means of a Flow-Through Device
- The Management of Clinical Laboratories in Europe: a FESCC Survey
- Meetings and Awards
Artikel in diesem Heft
- New Developments in Clinical Chemistry and Laboratory Medicine as Documented by EUROMEDLAB 2001 the 14th IFCC-FESCC European Congress of Clinical Chemistry and Laboratory Medicine, Prague, May 2631, 2001
- Haptoglobin Polymorphism and Body Iron Stores
- Immunohistochemistry in the Evaluation of Spermatogenesis and Sertoli Cell's Maturation Status
- Study of Therapy Resistance in Cancer Cells with Functional Proteome Analysis
- Proposition of an Aging Indicator from General Health Examination in France
- Comparison of Plasma Cardiac Troponins T and I in Chronically Hemodialyzed Patients in Relation to Cardiac Status and Age
- Medical and Economic Outcomes of Point-of-Care Testing
- Are Laboratory Investigations Recommended in Current Medical Practice Guidelines Supported by Available Evidence?
- New Aspects on Angiotensin-Converting Enzyme: from Gene to Disease
- Oxypurines, Protein, Glucose and the Functional State of Blood Vasculature Are Markers of Renal Calcium Stone-forming Processes? Observations in Men with Idiopathic Recurrent Calcium Urolithiasis
- Long-Chain Polyunsaturated Fatty Acids in Rat Maternal Milk, Offspring Brain and Peripheral Tissues in Essential Fatty Acid Deficiency
- Simultaneous Quantification of Sirolimus, Everolimus, Tacrolimus and Cyclosporine by Liquid Chromatography-Mass Spectrometry (LC-MS)
- Pancreatic Phospholipase A2 Activity in Acute Pancreatitis: a Prognostic Marker for Early Identification of Patients at Risk
- Serum Cytokeratin Fragment 21.1 (CYFRA 21.1) as Tumour Marker for Breast Cancer: Comparison with Carbohydrate Antigen 15.3 (CA 15.3) and Carcinoembryonic Antigen (CEA)
- Serum Cholesterol Levels in Neutropenic Patients with Fever
- Evaluation of Two Mg2+-Selective Electrodes by Means of a Flow-Through Device
- The Management of Clinical Laboratories in Europe: a FESCC Survey
- Meetings and Awards